Company · CIK 0000879169 · SIC 8731 — Services-Commercial Physical & Biological Research · Nasdaq
INCYTE CORP · INCY
Insider activity reported against this company. All insider holders · Files at: AGEN, MRUS. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 16, 2018 FForm 4 → | Jul 18, 4:28 pm EDT | Reid M HuberEVP, Chief Scientific Officer | 448 | $70.19 | $31,445 | 34,571 | — | plan? |
| Jul 16, 2018 FForm 4 → | Jul 18, 4:25 pm EDT | Herve HoppenotChairman / CEO, Director | 2,359 | $70.19 | $165,578 | 184,766 | — | plan? |
| Jul 16, 2018 FForm 4 → | Jul 18, 4:12 pm EDT | David W GryskaExecutive Vice President, CFO | 455 | $70.19 | $31,936 | 10,235 | — | plan? |
| Jul 16, 2018 FForm 4 → | Jul 18, 4:09 pm EDT | Barry P FlannellyEVP & General Manager US | 430 | $70.19 | $30,182 | 13,427 | — | plan? |
| Jul 9, 2018 SForm 4 → | Jul 11, 4:41 pm EDT | Paula J SwainEVP, Human Resources | 10,000 | $71.11 | $711,100 | 32,963 | −23.3% | plan? |
| Jul 9, 2018 MForm 4 → | Jul 11, 4:41 pm EDT | Paula J SwainEVP, Human Resources | 10,000 | $18.32 | $183,200 | 42,963 | — | plan? |
| Jul 9, 2018 SForm 4 → | Jul 11, 4:39 pm EDT | Vijay K IyengarEVP GPS, BD, & Licensing | 606 | $71.34 | $43,232 | 8,103 | −6.96% | plan? |
| Jul 5, 2018 FForm 4 → | Jul 5, 5:18 pm EDT | Herve HoppenotChairman / CEO, Director | 1,532 | $68.28 | $104,605 | 187,125 | — | plan? |
| Jul 5, 2018 FForm 4 → | Jul 5, 5:12 pm EDT | David W GryskaExecutive Vice President, CFO | 280 | $68.28 | $19,118 | 10,690 | — | plan? |
| Jul 5, 2018 FForm 4 → | Jul 5, 5:04 pm EDT | Reid M HuberEVP, Chief Scientific Officer | 284 | $68.28 | $19,392 | 35,019 | — | plan? |
| Jul 5, 2018 FForm 4 → | Jul 5, 4:58 pm EDT | Vijay K IyengarEVP GPS, BD, & Licensing | 273 | $68.28 | $18,640 | 8,709 | — | plan? |
| Jul 5, 2018 FForm 4 → | Jul 5, 4:49 pm EDT | Barry P FlannellyEVP & General Manager US | 273 | $68.28 | $18,640 | 13,857 | — | plan? |
| Jul 5, 2018 FForm 4 → | Jul 5, 4:45 pm EDT | Steven H SteinEVP & Chief Medical Officer | 262 | $68.28 | $17,889 | 15,197 | — | plan? |
| Jul 5, 2018 FForm 4 → | Jul 5, 4:28 pm EDT | Paula J SwainEVP, Human Resources | 404 | $68.28 | $27,585 | 32,963 | — | plan? |
| Jul 5, 2018 FForm 4 → | Jul 5, 4:22 pm EDT | Yao WenqingEVP, Head of Discovery Chem | 273 | $68.28 | $18,640 | 35,647 | — | plan? |
| Jul 2, 2018 AFForm 4 → | Jul 5, 4:24 pm EDT | Paul TrowerPrincipal Accounting Officer | 2,795 | $68.28 | $6,896 | 14,368 | — | plan? |
| Jun 29, 2018 AForm 4 → | Jul 3, 4:08 pm EDT | Jean Jacques BienaimeDirector | 216 | $67.00 | $14,472 | 5,459 | — | plan? |
| Jun 29, 2018 AForm 4 → | Jul 3, 4:06 pm EDT | Wendy L DixonDirector | 242 | $67.00 | $16,214 | 9,709 | — | plan? |
| Jun 29, 2018 AForm 4 → | Jul 3, 4:02 pm EDT | Jacqualyn A FouseDirector | 186 | $67.00 | $12,462 | 336 | — | plan? |
| Jun 29, 2018 AForm 4 → | Jul 3, 3:32 pm EDT | BAKER BROS. ADVISORS LP +6Director, 10% Owner | 849 | $67.00 | $56,883 | 810,289 | — | plan? |
| Jun 20, 2018 AGForm 4 → | Jul 3, 4:14 pm EDT | Paul A BrookeDirector | 40,354 | $67.00 | $23,718 | 198,213 | — | plan? late |
| Jun 4, 2018 MForm 4 → | Jun 6, 4:33 pm EDT | Paul A BrookeDirector | 20,000 | $2.80 | $56,000 | 217,859 | — | plan? |
| May 4, 2018 GForm 4 → | May 8, 4:12 pm EDT | Paul A BrookeDirector | 40,000 | — | — | 20,000 | — | plan? |
| May 2, 2018 PForm 4 → | May 3, 5:05 pm EDT | Herve HoppenotChairman / CEO, Director | 15,000 | $60.94 | $914,100 | 276,690 | +5.73% | plan? |
| May 2, 2018 MForm 4 → | May 3, 4:19 pm EDT | BAKER BROS. ADVISORS LP +6Director, 10% Owner | 60,000 | $9.92 | $595,200 | 810,006 | — | plan? |
| Apr 30, 2018 SForm 4 → | May 2, 5:04 pm EDT | Paula J SwainEVP, Human Resources | 80,000 | $62.43 | $4,994,400 | 33,367 | −70.6% | plan? |
| Apr 30, 2018 MForm 4 → | May 2, 5:04 pm EDT | Paula J SwainEVP, Human Resources | 80,000 | $17.79 | $1,423,200 | 107,267 | — | plan? |
| Apr 9, 2018 AForm 4 → | Apr 11, 4:54 pm EDT | Maria E PasqualeEVP & General Counsel | 5,928 | — | — | 6,141 | — | plan? |
| Apr 5, 2018 MForm 4 → | Apr 9, 5:01 pm EDT | Paul A BrookeDirector | 20,000 | $9.92 | $198,400 | 217,859 | — | plan? |
| Mar 29, 2018 AForm 4 → | Apr 3, 4:30 pm EDT | Jacqualyn A FouseDirector | 150 | $83.33 | $12,500 | 150 | — | plan? |
| Mar 29, 2018 AForm 4 → | Apr 3, 4:26 pm EDT | Wendy L DixonDirector | 195 | $83.33 | $16,249 | 9,467 | — | plan? |
| Mar 29, 2018 AForm 4 → | Apr 3, 4:23 pm EDT | Paul A BrookeDirector | 285 | $83.33 | $23,749 | 197,859 | — | plan? |
| Mar 29, 2018 AForm 4 → | Apr 3, 4:18 pm EDT | Jean Jacques BienaimeDirector | 174 | $83.33 | $14,499 | 5,243 | — | plan? |
| Mar 29, 2018 AForm 4 → | Apr 2, 5:59 pm EDT | BAKER BROS. ADVISORS LP +6Director, 10% Owner | 684 | $83.33 | $56,998 | 790,006 | — | plan? |
| Mar 2, 2018 FForm 4 → | Mar 6, 4:30 pm EST | Steven H SteinEVP & Chief Medical Officer | 2,081 | $86.61 | $180,235 | 15,459 | — | plan? |
| Feb 21, 2018 SForm 4 → | Feb 22, 4:46 pm EST | David W GryskaExecutive Vice President, CFO | 1,952 | $85.56 | $167,013 | 10,970 | −15.1% | plan? |
| Feb 21, 2018 SForm 4 → | Feb 22, 4:23 pm EST | Reid M HuberEVP, Chief Scientific Officer | 1,958 | $85.55 | $167,507 | 35,183 | −5.27% | plan? |
| Feb 20, 2018 FForm 4 → | Feb 22, 4:46 pm EST | David W GryskaExecutive Vice President, CFO | 1,070 | $86.03 | $92,052 | 12,922 | — | plan? |
| Feb 20, 2018 FForm 4 → | Feb 22, 4:29 pm EST | Yao WenqingEVP, Head of Discovery Chem | 1,026 | $86.03 | $88,267 | 35,584 | — | plan? |
| Feb 20, 2018 FForm 4 → | Feb 22, 4:23 pm EST | Reid M HuberEVP, Chief Scientific Officer | 1,064 | $86.03 | $91,536 | 37,141 | — | plan? |
| Feb 20, 2018 FForm 4 → | Feb 22, 4:18 pm EST | Paul TrowerPrincipal Accounting Officer | 414 | $86.03 | $35,616 | 11,439 | — | plan? |
| Feb 20, 2018 FForm 4 → | Feb 22, 4:15 pm EST | Paula J SwainEVP, Human Resources | 1,026 | $86.03 | $88,267 | 33,367 | — | plan? |
| Feb 20, 2018 FForm 4 → | Feb 22, 4:12 pm EST | Herve HoppenotChairman / CEO, Director | 37,314 | $86.03 | $3,210,123 | 261,690 | — | plan? |
| Feb 20, 2018 FForm 4 → | Feb 22, 4:10 pm EST | Barry P FlannellyEVP & General Manager US | 1,026 | $86.03 | $88,267 | 13,823 | — | plan? |
| Jan 5, 2018 SForm 4 → | Jan 9, 4:09 pm EST | David W GryskaExecutive Vice President, CFO | 6,760 | $98.87 | $668,361 | 13,992 | −32.6% | plan? |
| Jan 5, 2018 MForm 4 → | Jan 9, 4:09 pm EST | David W GryskaExecutive Vice President, CFO | 6,760 | $83.83 | $566,691 | 20,752 | — | plan? |
| Jan 2, 2018 SForm 4 → | Jan 3, 4:32 pm EST | Vijay K IyengarEVP GPS, BD, & Licensing | 5,000 | $97.26 | $486,300 | 8,676 | −36.6% | plan? |
| Jan 2, 2018 MForm 4 → | Jan 3, 4:32 pm EST | Vijay K IyengarEVP GPS, BD, & Licensing | 5,000 | $72.86 | $364,300 | 13,676 | — | plan? |
| Dec 29, 2017 AForm 4 → | Jan 3, 2018, 4:12 pm EST | Wendy L DixonDirector | 171 | $94.71 | $16,195 | 9,272 | — | plan? |
| Dec 29, 2017 AForm 4 → | Jan 3, 2018, 4:09 pm EST | Paul A BrookeDirector | 250 | $94.71 | $23,678 | 197,574 | — | plan? |
| Dec 29, 2017 AForm 4 → | Jan 3, 2018, 4:05 pm EST | BAKER BROS. ADVISORS LP +6Director, 10% Owner | 600 | $94.71 | $56,826 | 789,778 | — | plan? |
| Dec 29, 2017 AForm 4 → | Jan 3, 2018, 4:04 pm EST | Jean Jacques BienaimeDirector | 153 | $94.71 | $14,491 | 5,069 | — | plan? |
| Dec 1, 2017 SForm 4 → | Dec 5, 4:01 pm EST | Reid M HuberEVP, Chief Scientific Officer | 696 | $98.01 | $68,215 | 38,205 | −1.79% | plan? |
| Nov 16, 2017 SForm 4 → | Nov 20, 4:25 pm EST | Paul A FriedmanDirector | 28,507 | $105.24 | $3,000,077 | 269,011 | −9.58% | plan? |
| Nov 2, 2017 SForm 4 → | Nov 3, 4:01 pm EDT | David W GryskaExecutive Vice President, CFO | 3,915 | $105.63 | $413,541 | 13,992 | −21.9% | plan? |
| Nov 1, 2017 FForm 4 → | Nov 3, 4:01 pm EDT | David W GryskaExecutive Vice President, CFO | 3,913 | $107.96 | $422,447 | 17,907 | — | plan? |
| Sep 29, 2017 AForm 4 → | Oct 3, 5:30 pm EDT | BAKER BROS. ADVISORS LP +6Director, 10% Owner | 486 | $116.74 | $56,736 | 789,578 | — | plan? |
| Sep 29, 2017 AForm 4 → | Oct 3, 4:29 pm EDT | Wendy L DixonDirector | 139 | $116.74 | $16,227 | 9,101 | — | plan? |
| Sep 29, 2017 AForm 4 → | Oct 3, 4:21 pm EDT | Paul A BrookeDirector | 203 | $116.74 | $23,698 | 197,324 | — | plan? |
| Sep 29, 2017 AForm 4 → | Oct 3, 4:13 pm EDT | Jean Jacques BienaimeDirector | 124 | $116.74 | $14,476 | 4,916 | — | plan? |
| Sep 18, 2017 SForm 4 → | Sep 20, 4:28 pm EDT | Herve HoppenotChairman / CEO, Director | 70,502 | $119.45 | $8,421,464 | 299,004 | −19.1% | plan? |
| Sep 14, 2017 SForm 4 → | Sep 15, 4:11 pm EDT | Barry P FlannellyEVP & General Manager US | 714 | $124.25 | $88,715 | 14,782 | −4.61% | plan? |
| Sep 13, 2017 FForm 4 → | Sep 15, 4:39 pm EDT | Yao WenqingEVP, Head of Discovery Chem | 674 | $123.15 | $83,003 | 36,610 | — | plan? |
| Sep 13, 2017 FForm 4 → | Sep 15, 4:35 pm EDT | Paula J SwainEVP, Human Resources | 674 | $123.15 | $83,003 | 34,393 | — | plan? |
| Sep 13, 2017 FForm 4 → | Sep 15, 4:31 pm EDT | Steven H SteinEVP & Chief Medical Officer | 625 | $123.15 | $76,969 | 17,540 | — | plan? |
| Sep 13, 2017 FForm 4 → | Sep 15, 4:28 pm EDT | Eric H. SiegelEVP, General Counsel | 680 | $123.15 | $83,742 | 21,053 | — | plan? |
| Sep 13, 2017 FForm 4 → | Sep 15, 4:24 pm EDT | Reid M HuberEVP, Chief Scientific Officer | 692 | $123.15 | $85,220 | 38,862 | — | plan? |
| Sep 13, 2017 FForm 4 → | Sep 15, 4:19 pm EDT | Herve HoppenotChairman / CEO, Director | 2,486 | $123.15 | $306,151 | 369,506 | — | plan? |
| Sep 13, 2017 FForm 4 → | Sep 15, 4:14 pm EDT | David W GryskaExecutive Vice President, CFO | 712 | $123.15 | $87,683 | 21,820 | — | plan? |
| Sep 13, 2017 FForm 4 → | Sep 15, 4:11 pm EDT | Barry P FlannellyEVP & General Manager US | 674 | $123.15 | $83,003 | 15,496 | — | plan? |
| Sep 8, 2017 PForm 4 → | Sep 8, 5:06 pm EDT | BAKER BROS. ADVISORS LP +6Director, 10% Owner | 100,000 | $132.00 | $13,200,000 | 789,416 | +14.5% | plan? |
| Sep 5, 2017 SForm 4 → | Sep 7, 4:04 pm EDT | Paul TrowerPrincipal Accounting Officer | 3,000 | $138.41 | $415,230 | 11,853 | −20.2% | plan? |
| Sep 5, 2017 MForm 4 → | Sep 7, 4:04 pm EDT | Paul TrowerPrincipal Accounting Officer | 3,000 | $17.79 | $53,370 | 14,853 | — | plan? |
| Sep 1, 2017 SForm 4 → | Sep 5, 4:27 pm EDT | Eric H. SiegelEVP, General Counsel | 1,820 | $137.40 | $250,068 | 21,733 | −7.73% | plan? |
| Sep 1, 2017 MForm 4 → | Sep 5, 4:27 pm EDT | Eric H. SiegelEVP, General Counsel | 1,820 | $64.55 | $117,481 | 23,553 | — | plan? |
| Aug 31, 2017 SForm 4 → | Sep 5, 4:22 pm EDT | Paula J SwainEVP, Human Resources | 20,000 | $140.00 | $2,800,000 | 35,067 | −36.3% | plan? |
| Aug 31, 2017 MForm 4 → | Sep 5, 4:22 pm EDT | Paula J SwainEVP, Human Resources | 20,000 | $17.79 | $355,800 | 55,067 | — | plan? |
| Aug 29, 2017 SForm 4 → | Aug 31, 4:13 pm EDT | Steven H SteinEVP & Chief Medical Officer | 2,111 | $125.00 | $263,875 | 18,165 | −10.4% | plan? |
| Aug 29, 2017 MForm 4 → | Aug 31, 4:13 pm EDT | Steven H SteinEVP & Chief Medical Officer | 2,111 | $89.52 | $188,974 | 20,276 | — | plan? |
| Aug 4, 2017 SForm 4 → | Aug 7, 4:33 pm EDT | Paul TrowerPrincipal Accounting Officer | 3,000 | $125.25 | $375,750 | 11,853 | −20.2% | plan? |
| Aug 3, 2017 FMForm 4 → | Aug 7, 4:33 pm EDT | Paul TrowerPrincipal Accounting Officer | 3,295 | $27.48 | $90,534 | 14,853 | — | plan? |
| Aug 1, 2017 SForm 4 → | Aug 3, 4:54 pm EDT | Eric H. SiegelEVP, General Counsel | 1,820 | $132.92 | $241,914 | 21,733 | −7.73% | plan? |
| Aug 1, 2017 MForm 4 → | Aug 3, 4:54 pm EDT | Eric H. SiegelEVP, General Counsel | 1,820 | $64.55 | $117,481 | 23,553 | — | plan? |
| Jul 20, 2017 SForm 4 → | Jul 21, 4:01 pm EDT | Steven H SteinEVP & Chief Medical Officer | 6,485 | $131.09 | $850,119 | 18,165 | −26.3% | plan? |
| Jul 20, 2017 MForm 4 → | Jul 21, 4:01 pm EDT | Steven H SteinEVP & Chief Medical Officer | 6,485 | $85.68 | $555,641 | 24,650 | — | plan? |
| Jul 5, 2017 AForm 4 → | Jul 7, 5:03 pm EDT | Barry P FlannellyEVP & General Manager US | 3,517 | — | — | 16,170 | — | plan? |
| Jul 5, 2017 SForm 4 → | Jul 7, 5:02 pm EDT | Paul TrowerPrincipal Accounting Officer | 3,000 | $126.18 | $378,540 | 12,148 | −19.8% | plan? |
| Jul 5, 2017 AMForm 4 → | Jul 7, 5:02 pm EDT | Paul TrowerPrincipal Accounting Officer | 4,198 | $17.79 | $53,370 | 15,148 | — | plan? |
| Jul 5, 2017 AForm 4 → | Jul 7, 4:59 pm EDT | Herve HoppenotChairman / CEO, Director | 13,679 | — | — | 371,992 | — | plan? |
| Jul 5, 2017 AForm 4 → | Jul 7, 4:56 pm EDT | David W GryskaExecutive Vice President, CFO | 3,517 | — | — | 22,532 | — | plan? |
| Jul 5, 2017 AForm 4 → | Jul 7, 4:54 pm EDT | Yao WenqingEVP, Head of Discovery Chem | 3,517 | — | — | 37,284 | — | plan? |
| Jul 5, 2017 AForm 4 → | Jul 7, 4:51 pm EDT | Vijay K IyengarEVP GPS, BD, & Licensing | 3,517 | — | — | 8,510 | — | plan? |
| Jul 5, 2017 AForm 4 → | Jul 7, 4:50 pm EDT | Eric H. SiegelEVP, General Counsel | 3,517 | — | — | 21,733 | — | plan? |
| Jul 5, 2017 AForm 4 → | Jul 7, 4:46 pm EDT | Reid M HuberEVP, Chief Scientific Officer | 3,517 | — | — | 39,554 | — | plan? |
| Jul 5, 2017 AForm 4 → | Jul 7, 4:43 pm EDT | Paula J SwainEVP, Human Resources | 3,517 | — | — | 35,067 | — | plan? |
| Jul 5, 2017 AForm 4 → | Jul 7, 4:39 pm EDT | Steven H SteinEVP & Chief Medical Officer | 3,517 | — | — | 18,165 | — | plan? |
| Jul 3, 2017 SForm 4 → | Jul 5, 6:20 pm EDT | Eric H. SiegelEVP, General Counsel | 1,820 | $126.20 | $229,684 | 18,216 | −9.08% | plan? |
| Jul 3, 2017 MForm 4 → | Jul 5, 6:20 pm EDT | Eric H. SiegelEVP, General Counsel | 1,820 | $64.55 | $117,481 | 20,036 | — | plan? |
| Jun 30, 2017 AForm 4 → | Jul 5, 6:01 pm EDT | BAKER BROS. ADVISORS LP +6Director, 10% Owner | 450 | $125.91 | $56,660 | 787,387 | — | plan? |
| Jun 30, 2017 AForm 4 → | Jul 5, 4:23 pm EDT | Wendy L DixonDirector | 129 | $125.91 | $16,242 | 8,962 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 26, 2017 AForm 4 → | May 31, 4:33 pm EDT | Paul A FriedmanDirector | 15,000 | — | — | 15,000 | — | |
| May 26, 2017 AForm 4 → | May 31, 4:30 pm EDT | Wendy L DixonDirector | 15,000 | — | — | 15,000 | — | |
| May 26, 2017 AForm 4 → | May 31, 4:26 pm EDT | Paul J ClancyDirector | 15,000 | — | — | 15,000 | — | |
| May 26, 2017 AForm 4 → | May 31, 4:22 pm EDT | Paul A BrookeDirector | 15,000 | — | — | 15,000 | — | |
| May 26, 2017 AForm 4 → | May 31, 4:19 pm EDT | Jean Jacques BienaimeDirector | 15,000 | — | — | 15,000 | — | |
| May 5, 2017 MForm 4 → | May 9, 4:17 pm EDT | Paul TrowerPrincipal Accounting Officer | 3,000 | — | — | 31,187 | — | |
| May 1, 2017 MForm 4 → | May 2, 6:01 pm EDT | Barry P FlannellyEVP & General Manager US | 2,064 | — | — | 1,720 | — | |
| May 1, 2017 MForm 4 → | May 2, 5:52 pm EDT | Eric H. SiegelEVP, General Counsel | 1,820 | — | — | 20,212 | — | |
| Apr 28, 2017 MForm 4 → | May 2, 5:39 pm EDT | David W GryskaExecutive Vice President, CFO | 1,389 | — | — | 9,725 | — | |
| Apr 27, 2017 MForm 4 → | Apr 28, 5:10 pm EDT | BAKER BROS. ADVISORS LP +6Director, 10% Owner | 60,000 | — | — | 0 | — | |
| Apr 10, 2017 MForm 4 → | Apr 11, 4:19 pm EDT | Eric H. SiegelEVP, General Counsel | 4,043 | — | — | 22,032 | — | |
| Apr 10, 2017 MForm 4 → | Apr 11, 4:14 pm EDT | David W GryskaExecutive Vice President, CFO | 41,528 | — | — | 11,114 | — | |
| Apr 7, 2017 MForm 4 → | Apr 11, 4:24 pm EDT | Steven H SteinEVP & Chief Medical Officer | 32,000 | — | — | 13,262 | — | |
| Mar 17, 2017 MForm 4 → | Mar 20, 4:14 pm EDT | Paul A BrookeDirector | 20,000 | — | — | 0 | — | |
| Mar 16, 2017 MForm 4 → | Mar 20, 4:10 pm EDT | Paul A FriedmanDirector | 50,000 | — | — | 100,000 | — | |
| Feb 23, 2017 MForm 4 → | Feb 27, 4:54 pm EST | Paul A FriedmanDirector | 50,000 | — | — | 144,542 | — | |
| Feb 17, 2017 DForm 4 → | Feb 22, 7:49 pm EST | Julian Baker +6Director, 10% Owner | 533,500,000 | — | — | 0 | — | |
| Jan 17, 2017 AForm 4 → | Jan 19, 5:10 pm EST | Vijay K IyengarEVP GPS, BD, & Licensing | 18,865 | — | — | 879 | — | |
| Jan 17, 2017 AForm 4 → | Jan 19, 5:07 pm EST | Steven H SteinEVP & Chief Medical Officer | 37,956 | — | — | 879 | — | |
| Jan 17, 2017 AForm 4 → | Jan 19, 5:03 pm EST | Paul TrowerPrincipal Accounting Officer | 11,300 | — | — | 879 | — | |
| Jan 17, 2017 AForm 4 → | Jan 19, 4:59 pm EST | Yao WenqingEVP, Head of Discovery Chem | 37,956 | — | — | 879 | — | |
| Jan 17, 2017 AForm 4 → | Jan 19, 4:57 pm EST | Paula J SwainEVP, Human Resources | 19,091 | — | — | 19,091 | — | |
| Jan 17, 2017 AForm 4 → | Jan 19, 4:55 pm EST | Eric H. SiegelEVP, General Counsel | 19,091 | — | — | 19,091 | — | |
| Jan 17, 2017 AForm 4 → | Jan 19, 4:52 pm EST | Reid M HuberEVP, Chief Scientific Officer | 37,956 | — | — | 879 | — | |
| Jan 17, 2017 AForm 4 → | Jan 19, 4:48 pm EST | David W GryskaExecutive Vice President, CFO | 19,091 | — | — | 19,091 | — | |
| Jan 17, 2017 AForm 4 → | Jan 19, 4:35 pm EST | Barry P FlannellyEVP & General Manager US | 19,091 | — | — | 19,091 | — | |
| Jan 17, 2017 AForm 4 → | Jan 19, 4:33 pm EST | Herve HoppenotChairman / CEO, Director | 168,570 | — | — | 879 | — | |
| Nov 15, 2016 MForm 4 → | Nov 17, 4:29 pm EST | Paula J SwainEVP, Human Resources | 10,000 | — | — | 0 | — | |
| Oct 20, 2016 MForm 4 → | Oct 24, 4:44 pm EDT | Paula J SwainEVP, Human Resources | 10,000 | — | — | 2,317 | — | |
| Oct 7, 2016 MForm 4 → | Oct 11, 4:37 pm EDT | Reid M HuberEVP, Chief Scientific Officer | 11,709 | — | — | 0 | — | |
| Oct 7, 2016 MForm 4 → | Oct 11, 4:33 pm EDT | Barry P FlannellyEVP & General Manager US | 24,204 | — | — | 20,422 | — | |
| Sep 23, 2016 MForm 4 → | Sep 26, 4:34 pm EDT | Paula J SwainEVP, Human Resources | 20,000 | — | — | 12,317 | — | |
| Jul 29, 2016 MForm 4 → | Aug 2, 4:54 pm EDT | Paula J SwainEVP, Human Resources | 60,000 | — | — | 32,317 | — | |
| Jul 15, 2016 AForm 4 → | Jul 19, 4:46 pm EDT | Yao WenqingEVP, Head of Discovery Chem | 19,091 | — | — | 19,091 | — | |
| Jul 15, 2016 AForm 4 → | Jul 19, 4:45 pm EDT | Paul TrowerPrincipal Accounting Officer | 5,515 | — | — | 805 | — | |
| Jul 15, 2016 AForm 4 → | Jul 19, 4:45 pm EDT | Paula J SwainEVP, Human Resources | 19,091 | — | — | 596 | — | |
| Jul 15, 2016 AForm 4 → | Jul 19, 4:44 pm EDT | Steven H SteinEVP & Chief Medical Officer | 19,091 | — | — | 596 | — | |
| Jul 15, 2016 AForm 4 → | Jul 19, 4:43 pm EDT | Eric H. SiegelEVP, General Counsel | 19,091 | — | — | 596 | — | |
| Jul 15, 2016 AForm 4 → | Jul 19, 4:43 pm EDT | Reid M HuberEVP, Chief Scientific Officer | 19,091 | — | — | 19,091 | — | |
| Jul 15, 2016 AForm 4 → | Jul 19, 4:42 pm EDT | Herve HoppenotChairman / CEO, Director | 74,245 | — | — | 74,245 | — | |
| Jul 15, 2016 AForm 4 → | Jul 19, 4:41 pm EDT | David W GryskaExecutive Vice President, CFO | 19,091 | — | — | 596 | — | |
| Jul 15, 2016 AForm 4 → | Jul 19, 4:40 pm EDT | Barry P FlannellyEVP & General Manager US | 19,091 | — | — | 596 | — | |
| May 27, 2016 AForm 4 → | May 31, 5:53 pm EDT | Julian Baker +6Director, 10% Owner | 15,000 | — | — | 15,000 | — | |
| May 27, 2016 AForm 4 → | May 31, 4:30 pm EDT | Paul A FriedmanDirector | 15,000 | — | — | 15,000 | — | |
| May 27, 2016 AForm 4 → | May 31, 4:29 pm EDT | Wendy L DixonDirector | 15,000 | — | — | 15,000 | — | |
| May 27, 2016 AForm 4 → | May 31, 4:28 pm EDT | Paul J ClancyDirector | 15,000 | — | — | 15,000 | — | |
| May 27, 2016 AForm 4 → | May 31, 4:28 pm EDT | Paul A BrookeDirector | 15,000 | — | — | 15,000 | — | |
| May 27, 2016 AForm 4 → | May 31, 4:27 pm EDT | Jean Jacques BienaimeDirector | 15,000 | — | — | 15,000 | — | |
| May 9, 2016 AForm 4 → | May 11, 5:15 pm EDT | Vijay K IyengarEVP GPS, BD, & Licensing | 32,714 | — | — | 28,598 | — | |
| Apr 1, 2016 AForm 4 → | Apr 5, 4:30 pm EDT | Paul A BrookeDirector | 20,000 | — | — | 0 | — | |
| Mar 17, 2016 MForm 4 → | Mar 17, 7:14 pm EDT | Julian Baker +6Director, 10% Owner | 60,000 | — | — | 0 | — | |
| Feb 25, 2016 MForm 4 → | Feb 29, 4:28 pm EST | Yao WenqingEVP, Discovery Medicinal and P | 6,566 | — | — | 0 | — | |
| Feb 16, 2016 MForm 4 → | Feb 18, 4:31 pm EST | Reid M HuberEVP, Chief Scientific Officer | 5,377 | — | — | 0 | — | |
| Jan 15, 2016 MForm 4 → | Jan 20, 4:31 pm EST | Paula J SwainEVP, Human Resources | 13,531 | — | — | 0 | — | |
| Jan 15, 2016 MForm 4 → | Jan 20, 4:30 pm EST | Eric H. SiegelEVP, General Counsel | 2,509 | — | — | 2,223 | — | |
| Jan 7, 2016 AForm 4 → | Jan 8, 4:40 pm EST | Yao WenqingEVP, Discovery Medicinal and P | 32,415 | — | — | 1,044 | — | |
| Jan 7, 2016 AForm 4 → | Jan 8, 4:39 pm EST | Paul TrowerPrincipal Accounting Officer | 5,916 | — | — | 869 | — | |
| Jan 7, 2016 AForm 4 → | Jan 8, 4:39 pm EST | Paula J SwainEVP, Human Resources | 22,823 | — | — | 1,044 | — | |
| Jan 7, 2016 AForm 4 → | Jan 8, 4:38 pm EST | Eric H. SiegelEVP, General Counsel | 22,823 | — | — | 1,044 | — | |
| Jan 7, 2016 AForm 4 → | Jan 8, 4:37 pm EST | Reid M HuberEVP, Chief Scientific Officer | 40,998 | — | — | 1,044 | — | |
| Jan 7, 2016 AForm 4 → | Jan 8, 4:36 pm EST | Herve HoppenotChairman / CEO, Director | 95,333 | — | — | 1,044 | — | |
| Jan 7, 2016 AForm 4 → | Jan 8, 4:36 pm EST | David W GryskaExecutive Vice President, CFO | 22,823 | — | — | 1,044 | — | |
| Jan 7, 2016 AForm 4 → | Jan 8, 4:35 pm EST | Barry P FlannellyEVP & General Manager US | 22,823 | — | — | 1,044 | — | |
| Jan 6, 2016 MForm 4 → | Jan 8, 4:37 pm EST | Richard S LevyEVP, Chief Drug Dev Officer | 3,937 | — | — | 2,876 | — | |
| Dec 10, 2015 MForm 4 → | Dec 14, 4:32 pm EST | Eric H. SiegelEVP, General Counsel | 1,936 | — | — | 0 | — | |
| Dec 7, 2015 MForm 4 → | Dec 9, 4:31 pm EST | Richard S LevyEVP, Chief Drug Dev Officer | 3,937 | — | — | 6,813 | — | |
| Nov 17, 2015 MForm 4 → | Nov 19, 5:51 pm EST | Paul A FriedmanDirector | 225,000 | — | — | 0 | — | |
| Nov 10, 2015 MForm 4 → | Nov 12, 4:30 pm EST | Eric H. SiegelEVP, General Counsel | 2,222 | — | — | 4,732 | — | |
| Nov 6, 2015 MForm 4 → | Nov 10, 8:21 pm EST | Richard S LevyEVP, Chief Drug Dev Officer | 3,936 | — | — | 10,750 | — | |
| Nov 3, 2015 MForm 4 → | Nov 5, 4:47 pm EST | Yao WenqingEVP, Discovery Medicinal and P | 5,000 | — | — | 25,354 | — | |
| Oct 13, 2015 MForm 4 → | Oct 15, 4:30 pm EDT | Eric H. SiegelEVP, General Counsel | 2,222 | — | — | 5,018 | — | |
| Oct 6, 2015 MForm 4 → | Oct 8, 4:28 pm EDT | Richard S LevyEVP, Chief Drug Dev Officer | 3,937 | — | — | 14,686 | — | |
| Sep 21, 2015 MForm 4 → | Sep 23, 4:35 pm EDT | Reid M HuberEVP, Chief Scientific Officer | 10,000 | — | — | 11,709 | — | |
| Sep 16, 2015 MForm 4 → | Sep 18, 6:33 pm EDT | Julian Baker +6Director, 10% Owner | 40,575,000 | — | — | 0 | — | |
| Sep 16, 2015 MForm 4 → | Sep 18, 5:07 pm EDT | Eric H. SiegelEVP, General Counsel | 2,222 | — | — | 5,304 | — | |
| Sep 8, 2015 MForm 4 → | Sep 10, 4:44 pm EDT | Richard S LevyEVP, Chief Drug Dev Officer | 3,937 | — | — | 18,623 | — | |
| Aug 13, 2015 MForm 4 → | Aug 17, 4:20 pm EDT | Eric H. SiegelEVP, General Counsel | 2,222 | — | — | 5,590 | — | |
| Aug 7, 2015 MForm 4 → | Aug 10, 4:29 pm EDT | Reid M HuberEVP, Chief Scientific Officer | 8,397 | — | — | 5,377 | — | |
| Aug 6, 2015 MForm 4 → | Aug 10, 4:29 pm EDT | Richard S LevyEVP, Chief Drug Dev Officer | 3,936 | — | — | 22,560 | — | |
| Jul 15, 2015 MForm 4 → | Jul 16, 4:36 pm EDT | Richard S LevyEVP, Chief Drug Dev Officer | 70,217 | — | — | 0 | — | |
| Jul 14, 2015 MForm 4 → | Jul 16, 4:37 pm EDT | Yao WenqingEVP, Discovery Medicinal and P | 12,850 | — | — | 30,354 | — | |
| Jul 14, 2015 MForm 4 → | Jul 16, 4:37 pm EDT | Eric H. SiegelEVP, General Counsel | 2,222 | — | — | 6,449 | — | |
| Jul 6, 2015 MForm 4 → | Jul 8, 4:52 pm EDT | Richard S LevyEVP, Chief Drug Dev Officer | 3,937 | — | — | 26,496 | — | |
| Jun 23, 2015 MForm 4 → | Jun 25, 4:28 pm EDT | James M DalyEVP, Chief Commercial Officer | 11,691 | — | — | 17,662 | — | |
| Jun 19, 2015 MForm 4 → | Jun 23, 4:28 pm EDT | Richard S LevyEVP, Chief Drug Dev Officer | 20,000 | — | — | 70,217 | — | |
| Jun 12, 2015 MForm 4 → | Jun 16, 4:02 pm EDT | Eric H. SiegelEVP, General Counsel | 2,223 | — | — | 6,162 | — | |
| Jun 8, 2015 MForm 4 → | Jun 10, 4:43 pm EDT | Richard S LevyEVP, Chief Drug Dev Officer | 3,937 | — | — | 30,433 | — | |
| May 26, 2015 MForm 4 → | May 28, 4:32 pm EDT | Paul A FriedmanDirector | 196,751 | — | — | 0 | — | |
| May 26, 2015 MForm 4 → | May 28, 4:31 pm EDT | James M DalyEVP, Chief Commercial Officer | 12,093 | — | — | 18,643 | — | |
| May 22, 2015 AForm 4 → | May 27, 4:36 pm EDT | Jean Jacques BienaimeDirector | 15,000 | — | — | 15,000 | — | |
| May 22, 2015 AForm 4 → | May 27, 4:35 pm EDT | Paul A BrookeDirector | 15,000 | — | — | 15,000 | — | |
| May 22, 2015 AForm 4 → | May 27, 4:34 pm EDT | Paul J ClancyDirector | 15,000 | — | — | 15,000 | — | |
| May 22, 2015 AForm 4 → | May 27, 4:33 pm EDT | Wendy L DixonDirector | 15,000 | — | — | 15,000 | — | |
| May 22, 2015 AForm 4 → | May 27, 4:32 pm EDT | Paul A FriedmanDirector | 15,000 | — | — | 15,000 | — | |
| May 22, 2015 AForm 4 → | May 27, 4:02 pm EDT | Julian Baker +6Director, 10% Owner | 15,000 | — | — | 15,000 | — | |
| May 21, 2015 MForm 4 → | May 26, 4:57 pm EDT | Paul A FriedmanDirector | 102,243 | — | — | 196,751 | — | |
| May 18, 2015 AForm 4 → | May 20, 4:09 pm EDT | Paul A BrookeDirector | 20,000 | — | — | 0 | — | |
| May 14, 2015 MForm 4 → | May 15, 4:08 pm EDT | Eric H. SiegelEVP, General Counsel | 2,222 | — | — | 6,449 | — | |
| May 11, 2015 MForm 4 → | May 12, 6:58 pm EDT | Julian Baker +6Director, 10% Owner | 60,000 | — | — | 0 | — | |
| May 6, 2015 MForm 4 → | May 8, 4:02 pm EDT | Richard S LevyEVP, Chief Drug Dev Officer | 7,412 | — | — | 34,370 | — |
Filed by this entity as an insider elsewhere — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2017 PForm 4 → | Feb 14, 5:26 pm EST | AGENUS INCAGEN | 10,000,000 | $6.00 | $60,000,000 | 17,763,968 | +129% | plan? |
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.